Natixis Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.4M | Buy |
38,950
+12,296
| +46% | +$2.97M | 0.01% | 670 |
|
|
2025
Q1 | $6.49M | Sell |
26,654
-19,059
| -42% | -$4.64M | 0.01% | 747 |
|
|
2024
Q4 | $15M | Buy |
45,713
+4,390
| +11% | +$1.44M | 0.03% | 535 |
|
|
2024
Q3 | $13.8M | Buy |
41,323
+8,077
| +24% | +$2.7M | 0.03% | 555 |
|
|
2024
Q2 | $9.08M | Buy |
33,246
+5,564
| +20% | +$1.52M | 0.02% | 636 |
|
|
2024
Q1 | $9.57M | Buy |
27,682
+6,938
| +33% | +$2.4M | 0.02% | 620 |
|
|
2023
Q4 | $6.7M | Buy |
20,744
+3,152
| +18% | +$1.02M | 0.02% | 668 |
|
|
2023
Q3 | $6.31M | Buy |
17,592
+6,082
| +53% | +$2.18M | 0.02% | 641 |
|
|
2023
Q2 | $4.36M | Buy |
+11,510
| New | +$4.36M | 0.01% | 748 |
|
|
2021
Q2 | – | Sell |
-11,743
| Closed | -$6.71M | – | 1309 |
|
|
2021
Q1 | $6.71M | Sell |
11,743
-478
| -4% | -$273K | 0.04% | 506 |
|
|
2020
Q4 | $7.12M | Sell |
12,221
-574
| -4% | -$335K | 0.04% | 444 |
|
|
2020
Q3 | $6.6M | Buy |
12,795
+256
| +2% | +$132K | 0.04% | 431 |
|
|
2020
Q2 | $5.66M | Buy |
+12,539
| New | +$5.66M | 0.04% | 470 |
|
|
2014
Q3 | – | Sell |
-4,562
| Closed | -$546K | – | 1027 |
|
|
2014
Q2 | $546K | Buy |
4,562
+52
| +1% | +$6.22K | 0.01% | 979 |
|
|
2014
Q1 | $578K | Buy |
4,510
+279
| +7% | +$35.8K | 0.01% | 914 |
|
|
2013
Q4 | $523K | Sell |
4,231
-383
| -8% | -$47.3K | 0.01% | 884 |
|
|
2013
Q3 | $542K | Sell |
4,614
-42
| -0.9% | -$4.93K | 0.01% | 834 |
|
|
2013
Q2 | $522K | Buy |
+4,656
| New | +$522K | 0.01% | 811 |
|